Research classified by Journal of Economic Literature (JEL) codes

2002

• Joan-Ramon Borrell & Jayashree Watal, 2002, "Impact of Patents on Access to HIV/AIDS Drugs in Developing Countries," CID Working Papers, Center for International Development at Harvard University, number 92, May.
• Javier Guerrero Barón, 2002, "Mercados de violencia" y guerra civil en América Latina en los 90*"," Apuntes del Cenes, Universidad Pedagógica y Tecnológica de Colombia.
• Siotis, Georges & Marín Uribe, Pedro Luis, 2002, "Innovation and Market Structure: An Empirical Evaluation of the 'Bounds Approach' in the Chemical Industry," CEPR Discussion Papers, C.E.P.R. Discussion Papers, number 3162, Jan.
• Riccaboni, Massimo & Pammolli, Fabio, 2002, "On firm growth in networks," Research Policy, Elsevier, volume 31, issue 8-9, pages 1405-1416, December.
• Mª Carmen Fernández Díez, 2002, "Los derechos sobre las patentes biotecnológicas y su repercusión económica en la Unión Europea," EKONOMIAZ. Revista vasca de Economía, Gobierno Vasco / Eusko Jaurlaritza / Basque Government, volume 51, issue 03, pages 140-153.
• Jason Owen-Smith & Massimo Riccaboni & Fabio Pammolli & Walter W. Powell, 2002, "A Comparison of U.S. and European University-Industry Relations in the Life Sciences," Management Science, INFORMS, volume 48, issue 1, pages 24-43, January, DOI: 10.1287/mnsc.48.1.24.14275.
• Erik Biørn & Kjersti-Gro Lindquist & Terje Skjerpen, 2002, "Heterogeneity in Returns to Scale: A Random Coefficient Analysis with Unbalanced Panel Data," Journal of Productivity Analysis, Springer, volume 18, issue 1, pages 39-57, July, DOI: 10.1023/A:1015752426200.
• Frank Lichtenberg, 2002, "Benefits and Costs of Newer Drugs: An Update," NBER Working Papers, National Bureau of Economic Research, Inc, number 8996, Jun.
• Frank R. Lichtenberg & Suchin Virabhak, 2002, "Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as "equipment for your health"," NBER Working Papers, National Bureau of Economic Research, Inc, number 9351, Nov.
• Owen-Smith, Jason & Riccaboni, Massimo & Pammolli, Fabio & Powell, Walter W., 2002, "A Comparison of U.S. and European University-Industry Relations in the Life Sciences," MPRA Paper, University Library of Munich, Germany, number 15963.
• Gilroy, Bernard Michael & Vollpert, Tobias, 2002, "Economic Insights and Deficits in European Biotechnology Patent Policy," MPRA Paper, University Library of Munich, Germany, number 17979, May.
• Gilroy, Bernard Michael & Volpert, Tobias, 2002, "Economic Insights and Deficits in European Biotechnology Patent Policy," MPRA Paper, University Library of Munich, Germany, number 22619, May.
• Bernard Gilroy & Tobias Volpert, 2002, "Economic insights and deficits in European biotechnology patent policy," Intereconomics: Review of European Economic Policy, Springer;ZBW - Leibniz Information Centre for Economics;Centre for European Policy Studies (CEPS), volume 37, issue 3, pages 150-155, May, DOI: 10.1007/BF02928874.
• Dan Marsh, 2002, "Does New Zealand have an Innovation System for Biotechnology?," Working Papers in Economics, University of Waikato, number 02/03, Apr.
• Zwick, Thomas & Wolf, Elke & Beblo, Miriam, 2002, "Erfolgsabhängige Vergütung: Ein sicherer Weg zur Steigerung der Leistung von Top-Managern?," ZEW Discussion Papers, ZEW - Leibniz Centre for European Economic Research, number 02-72.

2001

• Andreas Pyka & Paolo Saviotti, 2001, "Innovation Networks in the Biotechnology-Based Sectors," Discussion Paper Series, Universitaet Augsburg, Institute for Economics, number 205, Jul.
• Andreas Pyka & Paul Windrum, 2001, "The Self-Organisation of Strategic Alliances," Discussion Paper Series, Universitaet Augsburg, Institute for Economics, number 209, Oct.
• Arora, Ashish & Fosfuri, Andrea & Gambardella, Alfonso, 2001, "Specialized technology suppliers, international spillovers and investment: evidence from the chemical industry," Journal of Development Economics, Elsevier, volume 65, issue 1, pages 31-54, June.
• Evans, R.G. & Morgan, S.G. & Barer, M.L., 2001, "Buying Science, Selling Drugs," Centre for Health Services and Policy Research, University of British Columbia - Centre for Health Services and Policy Research., number 2001:4r.
• Ostry, A., 2001, "The World Trade Organization and Publicly Funded Healthcare in Canada," Centre for Health Services and Policy Research, University of British Columbia - Centre for Health Services and Policy Research., number 2001:9r.
• Rey, P., 2001, "Research Incentives in Competing Markets: A Model of the Development of New Vaccines," Papers, Centro de Estudios Monetarios Y Financieros-, number 0102.
• Campart, S. & Pfister, E., 2001, "Innovation et marche financiers: l'impact des avancees therapeutiques sur les rentabilites boursieres des firmes," Papiers d'Economie Mathématique et Applications, Université Panthéon-Sorbonne (Paris 1), number 2001.28.
• Nicola Lacetera, 2001, "Corporate Governance and the Governance of Innovation: The Case of Pharmaceutical Industry," Journal of Management & Governance, Springer;Accademia Italiana di Economia Aziendale (AIDEA), volume 5, issue 1, pages 29-59, March, DOI: 10.1023/A:1017907119114.
• Frank R. Lichtenberg, 2001, "The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey," NBER Working Papers, National Bureau of Economic Research, Inc, number 8147, Mar.
• Alan T. Sorensen, 2001, "An Empirical Model of Heterogeneous Consumer Search for Retail Prescription Drugs," NBER Working Papers, National Bureau of Economic Research, Inc, number 8548, Oct.
• Riccaboni, Massimo & Pammolli, Fabio, 2001, "On Firm Growth in Networks," MPRA Paper, University Library of Munich, Germany, number 15964, Oct, revised 12 Nov 2001.
• Rainer Schweickert, 2001, "Restricciones Macroeconómicas al Desarrollo Económico y la Reducción de la Pobreza: El Caso de Bolivia," Documentos de trabajo, Instituto de Investigaciones Socio-Económicas (IISEC), Universidad Católica Boliviana, number 8/2001, Jul.
• Jason Owen-Smith & Massimo Riccaboni & Fabio Pammolli & Walter W. Powell, 2001, "A Comparison of U.S. And European University-Industry Relations in the Life Sciences," LEM Papers Series, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy, number 2001/03, Dec.
• Dan Marsh, 2001, "Modern Biotechnology in New Zealand: Further Analysis of Data from the Biotechnology Survey 1998/99," Working Papers in Economics, University of Waikato, number 01/03, Dec.
• Leon Taylor, 2001, "Do court-ordered breakups spur innovation?," Law and Economics, University Library of Munich, Germany, number 0105001, May.

2000

• Jaime de Melo & Marcelo Olarreaga & Wendy Takacs, 2000, "Pricing Policy Under Double Market Power: Madagascar and the International Vanilla Market," Review of Development Economics, Wiley Blackwell, volume 4, issue 1, pages 1-20, February, DOI: 10.1111/1467-9361.00075.
• Jaime MELO DE & Jean Marie GRETHER & Jean Claude MULLER, 2000, "The Political Economy of International Migration in a Ricardo-Viner Model," Working Papers, CERDI, number 200021.
• Nicola Lacetera, 2000, "Corporate Governance and the Governance of Innovation: the Case of Pharmaceutical Industry," KITeS Working Papers, KITeS, Centre for Knowledge, Internationalization and Technology Studies, Universita' Bocconi, Milano, Italy, number 122, Dec, revised Dec 2000.
• Franco Malerba & Luigi Orsenigo, 2000, "Towards a History Friendly Model of Innovation, Market Structure and Regulation in the Dynamics of the Pharmaceutical Industry: the Age of Random Screening," KITeS Working Papers, KITeS, Centre for Knowledge, Internationalization and Technology Studies, Universita' Bocconi, Milano, Italy, number 124, May, revised Jan 2001.
• Hamdouch, A. & Depret, M.-H., 2000, "Coalitions industrielles, reseaux de firmes et dynamiques de concurrence-cooperation dans les secteurs en cours de globalisation : le cas de l'industrie pharmaceutique," Papiers d'Economie Mathématique et Applications, Université Panthéon-Sorbonne (Paris 1), number 2000.24.
• Perrochon, D. & Lebert, D., 2000, "L'utilisation des notions de confiance et de proximite dans l'etude des processus de R&D pharmaceutiques," Papiers d'Economie Mathématique et Applications, Université Panthéon-Sorbonne (Paris 1), number 2000.56.
• Fairise, X. & Feve, P., 2000, "Heternenous Labor Demand and Aggregate Job Flows. Specification, Estimation and Testing with French Data," Papiers d'Economie Mathématique et Applications, Université Panthéon-Sorbonne (Paris 1), number 2000.59.
• Streb, J., 2000, "How to win Schumpeterian Competition. Technological Transfers in the German Plastics Industry from the 1930s to the 1970s," Papers, Yale - Economic Growth Center, number 811.
• Rudholm, Niklas, 2000, "Entry and the Number of firms in the Swedish Pharmaceuticals Market," Umeå Economic Studies, Umeå University, Department of Economics, number 541, Nov.
• Abdelillah Hamdouch & Marc-Hubert Depret, 2000, "Coalitions industrielles, réseaux de firmes et dynamiques de concurrence-coopération dans les secteurs en cours de globalisation : le cas de l'industrie pharmaceutique," Cahiers de la Maison des Sciences Economiques, Université Panthéon-Sorbonne (Paris 1), number r00024, Mar.
• Dominique Perrochon & Didier Lebert, 2000, "L'utilisation des notions de confiance et de proximité dans l'étude des processus de R&D pharmaceutiques," Cahiers de la Maison des Sciences Economiques, Université Panthéon-Sorbonne (Paris 1), number r00056, Jun.
• Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay, 2000, "Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs," NBER Working Papers, National Bureau of Economic Research, Inc, number 7772, Jun.
• Gambardella, Alfonso & Orsenigo, Luigi & Pammolli, Fabio, 2000, "Global Competitiveness in Pharmaceuticals: A European Perspective," MPRA Paper, University Library of Munich, Germany, number 15965, Nov.
• Arora, Ashish & Gambardella, Alfonso & Pammolli, Fabio & Riccaboni, Massimo, 2000, "The Nature and the Extent of the Market for Technology in Biopharmaceuticals," MPRA Paper, University Library of Munich, Germany, number 15977, Dec.
• Henry Grabowski & John Vernon, 2000, "The determinants of pharmaceutical research and development expenditures," Journal of Evolutionary Economics, Springer, volume 10, issue 1, pages 201-215.
• Erik Biørn & Kjersti-Gro Lindquist & Terje Skjerpen, 2000, "Heterogeneity in Returns to Scale: A Random Coefficient Analysis with Unbalanced Panel Data," Discussion Papers, Statistics Norway, Research Department, number 292, Dec.
• Dan Marsh, 2000, "Fostering Innovation in a Small Open Economy: The Case of the New Zealand Biotechnology Sector," Working Papers in Economics, University of Waikato, number 00/01, May.

1999

• Luis Alberto Zuleta Jaramillo & M�nica Lyli�n Parra Torrado, 1999, "Incidencia del régimen de patentes de la industria farmacéutica sobre la economía colombiana," Informes de Investigación, Fedesarrollo, number 2831, Jul.
• Jochen Streb, 1999, "How to Win Schumpeterian Competition: Technological Transfers in the German Plastics Industry from the 1930s to the 1970s," Working Papers, Economic Growth Center, Yale University, number 811, Sep.
• Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay, 1999, "Network Effects and Diffusion in Pharmaceutical Markets: Antiulcer Drugs," NBER Working Papers, National Bureau of Economic Research, Inc, number 7024, Mar.
• Michael M. Hopkins, 1999, "An Examination of Technology Strategies for the Integration of Bioinformatics in Pharmaceutical R&D Processes," SPRU Working Paper Series, SPRU - Science Policy Research Unit, University of Sussex Business School, number 32, Jun.

1998

• Aronsson, Thomas & Bergman, Mats A. & Rudholm, Niklas, 1998, "The Impact of Generic Competition on Brand Name Market Shares: Evidence from Micro Data," SSE/EFI Working Paper Series in Economics and Finance, Stockholm School of Economics, number 274, Oct.
• Aronsson, Thomas & Bergman, Mats & Rudholm, Niklas, 1998, "The Impact of Generic Competition on Brand Name Market Shares - Evidence from Micro Data," Umeå Economic Studies, Umeå University, Department of Economics, number 462, Feb.
• Berndt, Ernst R. & Pindyck, Robert S. & Azoulay, Pierre, 1970-, 1998, "Network effects and diffusion in pharmaceutical markets : antiulcer drugs," Working papers, Massachusetts Institute of Technology (MIT), Sloan School of Management, number WP 4059-98..
• Jean O. Lanjouw, 1998, "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," NBER Working Papers, National Bureau of Economic Research, Inc, number 6366, Jan.
• Havas, Attila, 1998, "International Co-operative Agreements in Hungary in the mid-1990s: Evolution, organisational forms and industry characteristics," MPRA Paper, University Library of Munich, Germany, number 68375, Feb.
• Maureen McKelvey, 1998, "Evolutionary innovations: learning, entrepreneurship and the dynamics of the firm," Journal of Evolutionary Economics, Springer, volume 8, issue 2, pages 157-175.
• Erik Biørn & Kjersti-Gro Lindquist, 1998, "Random Coefficients and Unbalanced Panels: An Application on Data from Norwegian Chemical Plants," Discussion Papers, Statistics Norway, Research Department, number 235, Oct.
• John Cantwell & Pllar Barrera, 1998, "The Localisation Of Corporate Technological Trajectories In The Interwar Cartels: Cooperative Learning Versus An Exchange Of Knowledge," Economics of Innovation and New Technology, Taylor & Francis Journals, volume 6, issue 2-3, pages 257-290, DOI: 10.1080/10438599800000022.
• Matthew Shum, 1998, "Characterizing Informational Barriers To Entry In The Anti-Ulcer Drug Market," Working Papers, University of Toronto, Department of Economics, number mshum-98-03, Oct.
• Rika Onishi Mortimer, 1998, "Demand for Prescription Drugs: The Effects of Managed Care Pharmacy Benefits," HEW, University Library of Munich, Germany, number 9802002, Feb.

1997

• Lanjouw, Jean O., 1997, "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," Center Discussion Papers, Yale University, Economic Growth Center, number 28385, DOI: 10.22004/ag.econ.28385.
• Jonathan Haskel & Pasquale Scaramozzino, 1997, "Do Other Firms Matter in Oligopolies?," Journal of Industrial Economics, Wiley Blackwell, volume 45, issue 1, pages 27-45, March, DOI: 10.1111/1467-6451.00033.
• Froissart, S., 1997, "Malaisie: Secteur de l'equipement medical de haute technologie," Papers, Ecole des Hautes Etudes Commerciales de Montreal-, number g97-01.
• Froissart, S., 1997, "Thailande: Secteur de l'equipement medical," Papers, Ecole des Hautes Etudes Commerciales de Montreal-, number g97-02.
• Froissart, S., 1997, "Belgique: Secteur de l'equipement medical haute technologie," Papers, Ecole des Hautes Etudes Commerciales de Montreal-, number g97-03.
• Froissart, S., 1997, "Chili:Secteur de l'equipement medical," Papers, Ecole des Hautes Etudes Commerciales de Montreal-, number g97-04.
• Theriault, V., 1997, "Israel: Secteur de l'equipement medical," Papers, Ecole des Hautes Etudes Commerciales de Montreal-, number g97-20.
• Randle, K., 1997, "Merger, Retionalisation and the "High Commitment" Organisation," Papers, University of Hertfordshire - Business Schoool, number 1997:3.
• Mattiuzzo, N. & Le Goff, J., 1997, "Les prestataires logistiques et la distribution pharmaceutique. Les barrieres a l'entree: vitres blindees ou glaces sans tain," Papers, Institut de Recherche en Gestion. Universite de Paris XII-, number 97-08.
• Lambert, J. & Srivastava, J. & Vietmeyer, N., 1997, "Medicinal Plants, Rescuing Global Heritage," Papers, World Bank - Technical Papers, number 355.
• Felker, G. & Chaudhuri, S. & Gyorgy, K. & Goldman, M., 1997, "The Pharmaceutical Industry in India and Hungary. Policies, Institutions, and Technological Development," Papers, World Bank - Technical Papers, number 392.
• Lanjouw, J.O., 1997, "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," Papers, Yale - Economic Growth Center, number 775.
• Tapon, F. & Thong, M., 1997, "Outsourcing of Research by Pharmaceutical and Biotechnology Firms," Working Papers, University of Guelph, Department of Economics and Finance, number 1997-2.
• Steven White & Xielin Liu, 1997, "Alternative Transition Trajectories for Complementary Asset Markets in China's Pharmaceutical Industry," Discussion Paper Series, Research Institute for Economics & Business Administration, Kobe University, number 83, Sep.
• Steven White, 1997, "Organizational Dynamics and Strcuture in the Chinese Pharmaceutical Industry: A Technological System Perspective," Discussion Paper Series, Research Institute for Economics & Business Administration, Kobe University, number 85, Oct.
• Steven White & Hideki Yoshihara & Xielin Liu, 1997, "Foreign Direct Investment, Technological Capabilities and Performance in the Chinese Pharmaceutical Industry," Discussion Paper Series, Research Institute for Economics & Business Administration, Kobe University, number 86, Oct.
• Fiona Scott Morton, 1997, "The Objectives of the FDA's Office of Generic Drugs," NBER Working Papers, National Bureau of Economic Research, Inc, number 6143, Aug.
• Fiona M. Scott Morton, 1997, "Entry Decisions in the Generic Pharmaceutical Industry," NBER Working Papers, National Bureau of Economic Research, Inc, number 6190, Sep.
• Sara Ellison Fisher & Iain Cockburn & Zvi Griliches & Jerry Hausman, 1997, "Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins," RAND Journal of Economics, The RAND Corporation, volume 28, issue 3, pages 426-446, Autumn.
• H. E. Frech, 1997, "Introduction," International Journal of the Economics of Business, Taylor & Francis Journals, volume 4, issue 3, pages 237-238, DOI: 10.1080/758523204.
• F. M. Scherer, 1997, "How US Antitrust Can Go Astray: The Brand Name Prescription Drug Litigation," International Journal of the Economics of Business, Taylor & Francis Journals, volume 4, issue 3, pages 239-256, DOI: 10.1080/758523205.
• Roy Weinstein & John Culbertson, 1997, "How US Antitrust Can Be On Target: The Brand-Name Prescription Drug Litigation," International Journal of the Economics of Business, Taylor & Francis Journals, volume 4, issue 3, pages 257-264, DOI: 10.1080/758523206.
• Peter Zweifel, 1997, "Comment on: F.M. Scherer, "How US Antitrust Can Go Astray: The Brand Name Prescription Drug Litigation"," International Journal of the Economics of Business, Taylor & Francis Journals, volume 4, issue 3, pages 277-278, DOI: 10.1080/758523209.
• W. Duncan Reekie, 1997, "Cartels, Spontaneous Price Discrimination and International Pharmacy Retailing," International Journal of the Economics of Business, Taylor & Francis Journals, volume 4, issue 3, pages 279-285, DOI: 10.1080/758523210.
• Kenneth Elzinga & David Mills, 1997, "The Distribution and Pricing of Prescription Drugs," International Journal of the Economics of Business, Taylor & Francis Journals, volume 4, issue 3, pages 287-300, DOI: 10.1080/758523211.
• Patricia Danzon, 1997, "Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU," International Journal of the Economics of Business, Taylor & Francis Journals, volume 4, issue 3, pages 301-322, DOI: 10.1080/758523212.
• Elli Malki, 1997, "Intellectual property and the valuation of biotechnology," Finance, University Library of Munich, Germany, number 9709002, Sep.
• Elli Malki, 1997, "The economic sense of royalty rates," Finance, University Library of Munich, Germany, number 9709003, Sep.
• Elli Malki, 1997, "Royalty rates, sub licensing considerations and joint ventures," Finance, University Library of Munich, Germany, number 9709004, Sep.
• Fiona M. Scott Morton, 1997, "The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules," Yale School of Management Working Papers, Yale School of Management, number ysm58, Jun.
• Bartsch, Elga, 1997, "Economic consequences of the German environmental liability act: Capital market response for the chemical industry," Kiel Working Papers, Kiel Institute for the World Economy, number 822.

1996

• Jaime MELO DE & OLARREAGA & TAKACS, 1996, "Pricing policy under Double Market Power: Madagascar and the International Vanilla Market," Working Papers, CERDI, number 199617.
• Randle, K., 1996, "Rewarding Failure: Performance Related Pay in a Pharmaceutical research and Development Company," Papers, University of Hertfordshire - Business Schoool, number 1996:1.
• Ellison, S & Cockburn, I & Griliches, A & Hausman, J, 1996, "Characteristics of Demand for Pharmaceutical Products : an Examination of four Cephalosporins," Working papers, Massachusetts Institute of Technology (MIT), Department of Economics, number 96-24.
• Ernst R. Berndt & Linda T. Bui & David H. Lucking-Reiley & Glen L. Urban, 1996, "The Roles of Marketing, Product Quality, and Price Competition in the Growth and Composition of the U.S. Antiulcer Drug Industry," NBER Chapters, National Bureau of Economic Research, Inc, "The Economics of New Goods".
• Rohini Acharya & Thomas Ziesemer, 1996, "A Closed Economy Model of Horizontal and Vertical Product Differentiation: The Case of Innovation in Biotechnology," Economics of Innovation and New Technology, Taylor & Francis Journals, volume 4, issue 3, pages 245-264, DOI: 10.1080/10438599600000012.

1995

• Lancia, G., 1995, "Genotyping by Combinatorial Optimization Techniques," GSIA Working Papers, Carnegie Mellon University, Tepper School of Business, number 1995-30.
• Haskel, Jonathan & Scaramozzino, Pasquale, 1995, "Do Other Firms Matter in Oligopolies?," CEPR Discussion Papers, C.E.P.R. Discussion Papers, number 1194, Jun.
• Joseph A. Dimasi & Grabowski, Henry G. & Vernon, John, 1995, "R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry," Working Papers, Duke University, Department of Economics, number 95-16.
• Paulo Guilherme Correa, 1995, "Regional integration, triangular trade and policy recommendations: the case of the Brazilian fine chemical industry," Brazilian Journal of Political Economy, Center of Political Economy, volume 15, issue 4, pages 517-535.
• Shigetomi, Shinichi, 1995, "The transmission of information in the transacting of primary products: the case of quality improvement in Thailand's natural rubber production," The Developing Economies, Institute of Developing Economies, Japan External Trade Organization(JETRO), volume 33, issue 2, pages 203-221, June.
• Joseph Dimasi & Henry Grabowski & John Vernon, 1995, "R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry," International Journal of the Economics of Business, Taylor & Francis Journals, volume 2, issue 2, pages 201-219, DOI: 10.1080/758519309.

1994

• Griliches, Zvi & Cockburn, Iain, 1994, "Generics and New Goods in Pharmaceutical Price Indexes," American Economic Review, American Economic Association, volume 84, issue 5, pages 1213-1232, December.
• Ernst R. Berndt & Linda Bui & David Reiley & Glen Urban, 1994, "The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry," NBER Working Papers, National Bureau of Economic Research, Inc, number 4904, Oct.
• J.E. Haskel & P. Scaramozzino, 1994, "Do Other Firms Matter in Oligopolies?," Working Papers, Queen Mary University of London, School of Economics and Finance, number 328, Jul.

1993

• F. M. Scherer, 1993, "Pricing, Profits, and Technological Progress in the Pharmaceutical Industry," Journal of Economic Perspectives, American Economic Association, volume 7, issue 3, pages 97-115, Summer.
• de Melo, Jaime & Winters, L. Alan, 1993, "Do exporters gain from VERs?," European Economic Review, Elsevier, volume 37, issue 7, pages 1331-1349, October.
• Griliches, Z. & Cockborn, I., 1993, "Generics and New Goods in Pharmaceutical Price Indexes," Harvard Institute of Economic Research Working Papers, Harvard - Institute of Economic Research, number 1664.
• Zvi Griliches & Iain Cockburn, 1993, "Generics and New Goods in Pharmaceutical Price Indexes," NBER Working Papers, National Bureau of Economic Research, Inc, number 4272, Feb.
• Rebecca Henderson & Iain Cockburn, 1993, "Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry," NBER Working Papers, National Bureau of Economic Research, Inc, number 4466, Sep.
• de Melo, Jaime & Panagariya, Arvind & Rodrik, Dani, 1993, "The new regionalism : a country perspective," Policy Research Working Paper Series, The World Bank, number 1094, Feb.

1991

• Faini, Riccardo & De Melo, Jaime & Senhadji, Abdelhak & Stanton, Julie, 1991, "Growth-oriented adjustment programs: A statistical analysis," World Development, Elsevier, volume 19, issue 8, pages 957-967, August.

1990

• de Melo, Jaime & Winters, L. Alan, 1990, "Do Exporters Gain From VERs?," CEPR Discussion Papers, C.E.P.R. Discussion Papers, number 383, Mar.
• Juan Blas Domínguez, 1990, "Aplicaciones de la biotecnología en la industria agroalimentaria," EKONOMIAZ. Revista vasca de Economía, Gobierno Vasco / Eusko Jaurlaritza / Basque Government, volume 16, issue 01, pages 156-171.
• Faini, Riccardo & de Melo, Jaime & Senhadji-Semlali,, 1990, "Growth oriented adjustment programs : a statistical analysis," Policy Research Working Paper Series, The World Bank, number 426, Jun.
• Faini, Riccardo & de Melo, Jaime, 1990, "Adjustment, investment, and the real exchange rate in developing countries," Policy Research Working Paper Series, The World Bank, number 473, Aug.

1987

• Devarajan, Shantayanan & de Melo, Jaime, 1987, "Adjustment with a Fixed Exchange Rate: Cameroon, Cote d'Ivoire, and Senegal," The World Bank Economic Review, World Bank, volume 1, issue 3, pages 447-487, May.

1986

• de Melo, Jaime & Urata, Shujiro, 1986, "The influence of increased foreign competition on industrial concentration and profitability," International Journal of Industrial Organization, Elsevier, volume 4, issue 3, pages 287-304, September.
• de Melo, Jaime & Tybout, James, 1986, "The Effects of Financial Liberalization on Savings and Investment in Uruguay," Economic Development and Cultural Change, University of Chicago Press, volume 34, issue 3, pages 561-587, April, DOI: 10.1086/451549.
• Corbo, Vittorio & de Melo, Jaime & Tybout, James, 1986, "What Went Wrong with the Recent Reforms in the Southern Cone," Economic Development and Cultural Change, University of Chicago Press, volume 34, issue 3, pages 607-640, April, DOI: 10.1086/451551.

1970

• Doris Hanzl-Weiss, 1970, "Development and Prospects of the Chemicals, Chemical Products and Man-made Fibres Sector in the Central and Eastern European Countries," wiiw Industry Study, The Vienna Institute for International Economic Studies, wiiw, number 2001_3, Jan.

0

• Raul Javier Orea-Monroy & Jose Fernando Guillen-Guzman, 2024, "Sustainable Innovation in Polyolefin Elastomers: Predictive Model for Hardness, Melt Flow Index and Expansion in Cross-linked Foams," Scientia et PRAXIS, AMIDI Editorial, volume 4, issue 8, pages 192-230, July-Dece, DOI: 10.55965/setp.4.08.a7.
• Fabio Pammolli & Dongfeng Fu & S. V. Buldyrev & Massimo Riccaboni & Kaushik Matia & Kazuko Yamasaki & H. E. Stanley, 2006, "A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence," Papers, arXiv.org, number physics/0609011, Sep.
• Carlos Gustavo Cano, 2009, "La ‘dominancia’ alimentaria de la política monetaria, biotecnología y política de tierras," Borradores de Economia, Banco de la Republica de Colombia, number 568, Jul, DOI: 10.32468/be.568.
• Martha Misas A. & Enrique López E. & Juan Carlos Parra A., 2009, "La formación de precios en las empresas colombianas: evidencia a partir de una encuesta directa," Borradores de Economia, Banco de la Republica de Colombia, number 569, Jul, DOI: 10.32468/be.569.
• BELLEFLAMME, Paul & van YPERSELE, Tanguy, 2006, "Comment favoriser l’innovation dans le secteur pharmaceutique: brevets et/ou récompenses ?," LIDAM Reprints CORE, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE), number 1920, Jan.
• Artjoms Ivlevs & Jaime de Melo, 2008, "FDI, the Brain Drain and Trade: Channels and Evidence," Discussion Papers, University of Nottingham, GEP, number 08/40.
• Kurt R Brekke & Michael Kuhn, , "Direct-to-Consumer Advertising in Pharmaceutical Markets," Discussion Papers, Department of Economics, University of York, number 03/11.

None

• Kyle Margaret, 2011, "Strategic Responses to Parallel Trade," The B.E. Journal of Economic Analysis & Policy, De Gruyter, volume 11, issue 2, pages 1-34, January, DOI: 10.2202/1935-1682.2629.
• Linnosmaa Ismo Erkki, 2008, "Advertising, Free-Riding, and Price Differences in the Market for Prescription Drugs," The B.E. Journal of Economic Analysis & Policy, De Gruyter, volume 8, issue 2, pages 1-37, July, DOI: 10.2202/1935-1682.1819.
• Simona Carmen Litescu & Sandra A.V. Eremia & Mirela Diaconu & Andreia Tache & Gabriel-Lucian Radu, 2011, "Biosensors Applications on Assessment of Reactive Oxygen Species and Antioxidants," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/16250.
• Ahmed Arafat & Muhammad A Daous, 2011, "Silicon and Silicon-Related Surfaces for Biosensor Applications," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/16254.
• Man Singh, 2011, "New Materials for Biosensor Construction," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/16272.
• Gab-Joo Chee, 2011, "Biosensor for the Determination of Biochemical Oxygen Demand in Rivers," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/16370.
• Katrine Kiilerich-Hansen & Claus R. Poulsen & Johannes Dapra & Nikolaj O. Christiansen & Noemi Rozlosnik, 2011, "Polymer Based Biosensors for Pathogen Diagnostics," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/16390.
• Liliana Serna & Jeyson Perenguez-Verdugo, 2011, "Biosensors Applications in Agri-food Industry," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/16744.
• Seyda Korkut Ozoner & Elif Erhan & Faruk Yilmaz, 2011, "Enzyme based phenol biosensors," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/16998.
• Monika Hoskovcova & Zbynek Kobliha, 2011, "Modified Cholinesterase Technology in the Construction of Biosensors for Organophosphorus Nerve Agents and Pesticides Detection," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/17040.
• Mitsuhiro Shimojo & Kei Amada & Hidekazu Koya & mitsuyasu kawakami, 2011, "Flow Injection Biosensor System for 2,4-Dichlorophenoxyacetate Based on a Microbial Reactor and Tyrosinase-modified Electrode," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/17113.
• Angela Winstead & Richard Williams, 2011, "Application of Microwave Assisted Organic Synthesis to the Development of Near-IR Cyanine Dye Probes," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/17315.
• Robert Valentin Sandulescu & Cecilia Cristea & Veronica Harceaga & Ede Bodoki, 2011, "Electrochemical sensors and biosensors for the pharmaceutical and environmental analysis," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/17642.
• Daniel Shelton & Shuhong Li & Peixuan Zhu & Daniel Adams & Platte Amstutz & Lynda Kiefer & Cha-Mei Tang, 2011, "Ultra-sensitive fluorescence detection using integrated waveguide technology," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/18429.
• Jadwiga Soloducho & Joanna Cabaj, 2011, "Hybrid Film Biosensor for Phenolic Compounds Detection," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/19655.
• Florence Lagarde & Nicole jaffrezic-Renault, 2011, "New Trends in Biosensors for Water Monitoring," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/19945.
• Andrea Medeiros Salgado & Livia Maria da Costa Silva & Ariana Farias Melo, 2011, "Biosensor for Environmental Applications," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/20154.
• Maria DeRosa, 2011, "Advances in Aptamer-Based Biosensors for Food Safety," Chapters, IntechOpen, in: Vernon Somerset, "Environmental Biosensors", DOI: 10.5772/22350.